Gustavo Cabrera

578 total citations
19 papers, 354 citations indexed

About

Gustavo Cabrera is a scholar working on Physiology, Epidemiology and Rheumatology. According to data from OpenAlex, Gustavo Cabrera has authored 19 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 9 papers in Epidemiology and 6 papers in Rheumatology. Recurrent topics in Gustavo Cabrera's work include Lysosomal Storage Disorders Research (17 papers), Trypanosoma species research and implications (9 papers) and Glycogen Storage Diseases and Myoclonus (6 papers). Gustavo Cabrera is often cited by papers focused on Lysosomal Storage Disorders Research (17 papers), Trypanosoma species research and implications (9 papers) and Glycogen Storage Diseases and Myoclonus (6 papers). Gustavo Cabrera collaborates with scholars based in Argentina, United States and France. Gustavo Cabrera's co-authors include Juan Politei, Joel Charrow, David G. Warnock, Stephen Waldek, Manesh R. Patel, Dominique P. Germain, Robert J. Hopkin, Alberto Ortíz, Michael Mauer and Ademola K. Abiose and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medical Genetics and Genetics in Medicine.

In The Last Decade

Gustavo Cabrera

17 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gustavo Cabrera Argentina 10 297 163 85 79 71 19 354
Chuan‐Hong Kao Taiwan 7 204 0.7× 103 0.6× 102 1.2× 50 0.6× 158 2.2× 10 411
Linda van der Tol Netherlands 7 493 1.7× 234 1.4× 156 1.8× 161 2.0× 78 1.1× 10 529
Toju Tanaka Japan 10 274 0.9× 121 0.7× 106 1.2× 43 0.5× 101 1.4× 16 417
Nobuyuki Ishige Japan 8 259 0.9× 149 0.9× 57 0.7× 83 1.1× 54 0.8× 12 302
Desnick Rj United States 9 219 0.7× 63 0.4× 72 0.8× 69 0.9× 79 1.1× 25 307
Ken Suzuki Japan 7 286 1.0× 143 0.9× 61 0.7× 82 1.0× 92 1.3× 8 348
Donna L. Bernstein United States 4 214 0.7× 63 0.4× 53 0.6× 14 0.2× 76 1.1× 6 318
Kristin Kampevold Larsen Norway 7 334 1.1× 127 0.8× 123 1.4× 84 1.1× 51 0.7× 9 369
Sam Beeckman Belgium 5 220 0.7× 36 0.2× 111 1.3× 98 1.2× 55 0.8× 6 455
Zhengqing Qiu China 10 95 0.3× 31 0.2× 75 0.9× 49 0.6× 78 1.1× 40 273

Countries citing papers authored by Gustavo Cabrera

Since Specialization
Citations

This map shows the geographic impact of Gustavo Cabrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gustavo Cabrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gustavo Cabrera more than expected).

Fields of papers citing papers by Gustavo Cabrera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gustavo Cabrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gustavo Cabrera. The network helps show where Gustavo Cabrera may publish in the future.

Co-authorship network of co-authors of Gustavo Cabrera

This figure shows the co-authorship network connecting the top 25 collaborators of Gustavo Cabrera. A scholar is included among the top collaborators of Gustavo Cabrera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gustavo Cabrera. Gustavo Cabrera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Cabrera, Gustavo, et al.. (2025). New Drugs Available for Fabry Disease. Kidney & Blood Pressure Research. 50(1). 366–374.
2.
Hopkin, Robert J., Gustavo Cabrera, John L. Jefferies, et al.. (2022). Clinical outcomes among young patients with Fabry disease who initiated agalsidase beta treatment before 30 years of age: An analysis from the Fabry Registry. Molecular Genetics and Metabolism. 138(2). 106967–106967. 13 indexed citations
3.
Laney, Dawn A., Dominique P. Germain, João Paulo Oliveira, et al.. (2021). Fabry disease and COVID-19: International expert recommendations for management based on real-world experience. Molecular Genetics and Metabolism. 132(2). S62–S62. 1 indexed citations
4.
Laney, Dawn A., Dominique P. Germain, João Paulo Oliveira, et al.. (2020). Fabry disease and COVID-19: international expert recommendations for management based on real-world experience. Clinical Kidney Journal. 13(6). 913–925. 11 indexed citations
5.
6.
Cabrera, Gustavo, et al.. (2017). Effectiveness of enzyme replacement therapy in Fabry disease: Long term experience in Argentina. Molecular Genetics and Metabolism Reports. 11. 65–68. 2 indexed citations
7.
Cabrera, Gustavo, et al.. (2016). Evaluación pre trasplante renal en el paciente con Enfermedad de Fabry. 37(2). 9–17. 1 indexed citations
8.
Hopkin, Robert J., Gustavo Cabrera, Joel Charrow, et al.. (2016). Risk factors for severe clinical events in male and female patients with Fabry disease treated with agalsidase beta enzyme replacement therapy: Data from the Fabry Registry. Molecular Genetics and Metabolism. 119(1-2). 151–159. 41 indexed citations
9.
Cabrera, Gustavo. (2016). Update on Coronary Involvement in Fabry Disease. SHILAP Revista de lepidopterología. 4. 4078080102–4078080102. 1 indexed citations
10.
Ortíz, Alberto, Ademola K. Abiose, Daniel G. Bichet, et al.. (2016). Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry. Journal of Medical Genetics. 53(7). 495–502. 103 indexed citations
11.
Politei, Juan, et al.. (2015). Fabry disease and enzyme replacement therapy in classic patients with same mutation: different formulations – different outcome?. Clinical Genetics. 89(1). 88–92. 13 indexed citations
12.
Politei, Juan, et al.. (2014). Vertebrobasilar Dolichoectasia in Fabry Disease. SHILAP Revista de lepidopterología. 2. 4077866284–4077866284. 17 indexed citations
13.
Germain, Dominique P., Frank Weidemann, Ademola K. Abiose, et al.. (2013). Analysis of left ventricular mass in untreated men and in men treated with agalsidase-β: data from the Fabry Registry. Genetics in Medicine. 15(12). 958–965. 70 indexed citations
14.
Cabrera, Gustavo, et al.. (2012). Left ventricular aneurysm in an adult patient with mucopolysaccharidosis type I: Comment on pathogenesis of a novel complication. Molecular Genetics and Metabolism. 106(4). 470–473. 4 indexed citations
15.
Villalobos, Jacobo, Juan Politei, Ana María Martins, et al.. (2012). Fabry Disease in Latin America: Data from the Fabry Registry. JIMD Reports. 8. 91–99. 13 indexed citations
16.
Politei, Juan, et al.. (2012). Fabry disease in Argentina: an evaluation of patients enrolled in the Fabry Registry. International Journal of Clinical Practice. 67(1). 66–72. 4 indexed citations
17.
Cabrera, Gustavo & Juan Politei. (2011). Interrupción de la terapia de reemplazo enzimático en la enfermedad de Fabry: mala evolución a propósito de un caso. Neurología Argentina. 3(2). 113–116. 2 indexed citations
18.
Cabrera, Gustavo, et al.. (2000). Acute renal insufficiency after colon cleansing.. PubMed. 32(2). S11–S11. 2 indexed citations
19.
Rubin, Peter, et al.. (1992). Phase II study of the safety and efficacy of a 5-lipoxygenase inhibitor in patients with ulcerative colitis.. PubMed. 87(3). 342–6. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chuan‐Hong Kao Breakdown of academic impact, for papers by Linda van der Tol Breakdown of academic impact, for papers by Toju Tanaka Breakdown of academic impact, for papers by Nobuyuki Ishige Breakdown of academic impact, for papers by Desnick Rj Breakdown of academic impact, for papers by Ken Suzuki Breakdown of academic impact, for papers by Donna L. Bernstein Breakdown of academic impact, for papers by Kristin Kampevold Larsen Breakdown of academic impact, for papers by Sam Beeckman Breakdown of academic impact, for papers by Zhengqing Qiu
Rankless by CCL
2026